Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Infantino

Showing results (61-70 of 151) with videos related to

Pageof 16
Sort By:
Journal of Personalized Medicine|February 25, 2023
Correction: Benucci et al. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. <i>J. Pers. Med.</i> 2022, <i>12</i>, 1174Maurizio Benucci, Arianna Damiani, Francesca Bandinelli, et al.
The Israel Medical Association Journal : IMAJ|February 13, 2018
Ankylosing Spondylitis Treatment after First Anti-TNF Drug FailureMaurizio Benucci, Arianna Damiani, Francesca Bandinelli, et al.
Clinical Rheumatology|January 9, 2019
Improved accuracy in DFS pattern interpretation using a novel HEp-2 ELITE systemMaria Infantino, O Shovman, B Gilburd, et al.
Journal of Personalized Medicine|December 23, 2022
The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine PerspectiveMaurizio Benucci, Arianna Damiani, Edda Russo, et al.
Antibodies (Basel, Switzerland)|August 22, 2025
Anti-HMGCR-Antibody-Positive Statin-Induced Myositis: A Pilot Case Series on Treatment with Bempedoic Acid and Immunosuppressive TherapyMaurizio Benucci, Riccardo Terenzi, Francesca Li Gobbi, et al.
Journal of Translational Autoimmunity|July 18, 2025
An international multicenter retrospective analysis of repeated anti-ENA testing in ANA-associated rheumatic diseases, a data-driven proposal to increase testing efficacyWim H M Vroemen, Maria Infantino, Mariangela Manfredi, et al.
The Open Rheumatology Journal|October 12, 2013
No Correlations Between the Development of Specific IgA and IgM Antibodies Against Anti-TNF Blocking Agents, Disease Activity and Adverse Side Reactions in Patients with Rheumatoid ArthritisMaurizio Benucci, Gianantonio Saviola, Francesca Meacci, et al.
Journal of Personalized Medicine|December 24, 2025
Biopsy-Driven Synovial Pathophenotyping in RA: A New Approach to Personalized TreatmentSheyda Ketabchi, Edda Russo, Maurizio Benucci, et al.
Clinical Chemistry and Laboratory Medicine|June 3, 2025
A comparison of current methods to measure antibodies in type 1 diabetesMaria Infantino, Mariangela Manfredi, Emirena Garrafa, et al.
Case Reports in Neurological Medicine|February 29, 2020
Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 AntibodiesMaurizio Benucci, Luciana Tramacere, Maria Infantino, et al.
Pageof 16

Showing results (61-70 of 151) with videos related to

Sort By:
Pageof 16
Journal of Personalized Medicine|February 25, 2023
Correction: Benucci et al. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. <i>J. Pers. Med.</i> 2022, <i>12</i>, 1174Maurizio Benucci, Arianna Damiani, Francesca Bandinelli, et al.
The Israel Medical Association Journal : IMAJ|February 13, 2018
Ankylosing Spondylitis Treatment after First Anti-TNF Drug FailureMaurizio Benucci, Arianna Damiani, Francesca Bandinelli, et al.
Clinical Rheumatology|January 9, 2019
Improved accuracy in DFS pattern interpretation using a novel HEp-2 ELITE systemMaria Infantino, O Shovman, B Gilburd, et al.
Journal of Personalized Medicine|December 23, 2022
The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine PerspectiveMaurizio Benucci, Arianna Damiani, Edda Russo, et al.
Antibodies (Basel, Switzerland)|August 22, 2025
Anti-HMGCR-Antibody-Positive Statin-Induced Myositis: A Pilot Case Series on Treatment with Bempedoic Acid and Immunosuppressive TherapyMaurizio Benucci, Riccardo Terenzi, Francesca Li Gobbi, et al.
Journal of Translational Autoimmunity|July 18, 2025
An international multicenter retrospective analysis of repeated anti-ENA testing in ANA-associated rheumatic diseases, a data-driven proposal to increase testing efficacyWim H M Vroemen, Maria Infantino, Mariangela Manfredi, et al.
The Open Rheumatology Journal|October 12, 2013
No Correlations Between the Development of Specific IgA and IgM Antibodies Against Anti-TNF Blocking Agents, Disease Activity and Adverse Side Reactions in Patients with Rheumatoid ArthritisMaurizio Benucci, Gianantonio Saviola, Francesca Meacci, et al.
Journal of Personalized Medicine|December 24, 2025
Biopsy-Driven Synovial Pathophenotyping in RA: A New Approach to Personalized TreatmentSheyda Ketabchi, Edda Russo, Maurizio Benucci, et al.
Clinical Chemistry and Laboratory Medicine|June 3, 2025
A comparison of current methods to measure antibodies in type 1 diabetesMaria Infantino, Mariangela Manfredi, Emirena Garrafa, et al.
Case Reports in Neurological Medicine|February 29, 2020
Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 AntibodiesMaurizio Benucci, Luciana Tramacere, Maria Infantino, et al.
Pageof 16